Guidelines
he Scientific Committee of the 20th International Congress of the International Society for Ethnopharmacology welcomes the submission of original abstracts according to the following submission guidelines the latest by 10 January, 2020 20 January, 2020 27 January, 2020.
The submitted abstracts will be assessed, peer-reviewed and grouped by topic. Accepted abstracts will be considered for oral or poster presentations. All abstracts as oral or poster form will be published in the book of abstracts.
SUBMISSION OF ABSTRACT & GUIDELINES
Abstracts must be submitted not later than 10 January, 2020 20 January, 2020 27 January, 2020 by filling in the online submission form. Abstracts received after that deadline will not be considered. It is required that for each accepted abstract at least one of the authors has pre-registered. Authors are exclusively responsible for the submission of their presentation according to the abstract submission guidelines and for submitting their abstract in due time according to the abstract submission deadline. If guidelines are not followed, abstracts will be returned to sender/writer for corrections. Therefore, timely abstract submission is recommended. In case the submitted abstract does not respect the rules and there is not time for correction due to the abstracts deadline, it will be disqualified automatically. All scientific contributions (posters and orals) are subjected to an extensive review process. After evaluation corresponding authors will receive feedback. In case you find any difficulty in submitting your abstract electronically, please contact ARTION Conferences & Events at ethnopharmacology2021@artion.com.gr. The Scientific Committee reserves the right to include a presentation according to the needs of the Congress’ Scientific Program or even change the requested presentation type from oral to poster.
ABSTRACT CONTENT
Abstract content
Software – Abstracts should be typed on a word processor (“.doc” or “.docx” format).
Font, size, spacing, alignment – They should be written in Calibri font 11 pt, single-spaced, without spaces between paragraphs and justified paragraph alignment.
Spacing, paragraphs – The first line of paragraphs should not be indented. There should be no spaces between paragraphs: title, authors and affiliated institutions/hospitals. There should be one single space between the affiliated institutions/hospitals and the abstract text.
Title –The title should be in Bold sentence-case letters, as brief as possible (no more than two lines) and it should not contain information that reveal the source of the abstract.
Authors – All of the names should be written in the nominative in Sentence-case letters; the surname should follow the first initial of the name; and the superscript should be inserted at the end with no space. The presenter’s name should be underlined; the superscript should not be underlined. Listed names should be separated by a comma, e.g.
- Papadopoulou1, A. Papadopoulos2
Address of institution – The name of the institution should precede the location, if the location is not included in the name of the institution (e.g. Spine and Scoliosis Unit, “KAT” General Hospital of Attica, Greece or Department of Neurosurgery, 424 Army General Hospital, Thessaloniki, Greece). When more than one institution is mentioned, the reference superscripts should be written before the name, e.g.
- Papadopoulou1, A. Papadopoulos2
1 Spine and Scoliosis Unit, “KAT” General Hospital of Attica, Greece
2 Department of Neurosurgery, 424 Army General Hospital, Thessaloniki, Greece
Abbreviations may be used after the reference has been written out in full in parentheses after their first appearance in the text. The text should be no longer than 300 words.
The abstracts submitted will be assessed, peer reviewed and grouped by topic. Accepted abstracts will be presented as oral or poster presentations. All presented abstracts as oral or poster form will be published in the book of abstracts.